情报工程
情報工程
정보공정
Technology Intelligence Engineering
2015年
3期
19-30
,共12页
日本版NIH%药物%专利%指标%研究开发%循证政策%全球疾病负担研究%残疾调整生命年%国际专利分类
日本版NIH%藥物%專利%指標%研究開髮%循證政策%全毬疾病負擔研究%殘疾調整生命年%國際專利分類
일본판NIH%약물%전리%지표%연구개발%순증정책%전구질병부담연구%잔질조정생명년%국제전리분류
Japanese version of the NIH%Pharmaceuticals%Patents%Indicators%Research and development%Evidence based policy%Global burden of diseases%Disability-adjusted life year%International Patent Classiifcations
AMED(日本版NIH)及其制药企业,政策制定·战略规划需要佐证.为此,本研究尝试基于新的指标体系进行制药行业的现状俯瞰与未来预测.本篇从药物与在研药物的适用症角度出发,分析不同种类疾病的药物开发现状.具体来说,进行了基于国际专利分类(IPC)的分析及其各种疾病的分析.
AMED(日本版NIH)及其製藥企業,政策製定·戰略規劃需要佐證.為此,本研究嘗試基于新的指標體繫進行製藥行業的現狀俯瞰與未來預測.本篇從藥物與在研藥物的適用癥角度齣髮,分析不同種類疾病的藥物開髮現狀.具體來說,進行瞭基于國際專利分類(IPC)的分析及其各種疾病的分析.
AMED(일본판NIH)급기제약기업,정책제정·전략규화수요좌증.위차,본연구상시기우신적지표체계진행제약행업적현상부감여미래예측.본편종약물여재연약물적괄용증각도출발,분석불동충류질병적약물개발현상.구체래설,진행료기우국제전리분류(IPC)적분석급기각충질병적분석.
For the sake of providing evidences that contribute to policy making or strategy planning in a Japanese version of the NIH and pharmaceutical companies, we tried an overview and future prospects of pharmaceutical industry based on new indicators. Here we show the trends of drug R&D by type of disease, focusing on the indication that each R&D pipeline has. In particular, we analyze drug R&D by International Patent Classiifcations (IPC) and individual diseases.
